Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Compounds that trigger the growth of new brain cells might help treat depression.
A high-resolution, lens-free microscope fits on a dime-size chip.
A new startup, funded with $40 million from Third Rock Ventures, will develop drugs aimed at molecularly defined cancers.
A drugmaker is testing an alternative to diabetes injections, but many sizable hurdles remain.
A startup called Catabasis is developing drugs that hit diseases at multiple targets.
Drugmakers place big bets on the emerging science of microRNA.
Scientists hope to harness the organisms’ immune-regulating effects.
A startup will sift through “treasure troves” of data from failed trials to find abandoned Alzheimer’s drugs that might work for some patients.